Can a dirt-cheap diabetes drug fight cancer?
By Anne Harding, Health.com
April 6, 2012 -- Updated 1117 GMT (1917 HKT)
snip
In another study, researchers from the University of Texas MD Anderson Cancer Center, in Houston, found that metformin was associated with better outcomes in diabetes patients with pancreatic cancer, an especially aggressive form of cancer.
The two-year survival rate was 30% among the 117 patients taking metformin and just 15% among 185 patients not on the drug.
By Anne Harding, Health.com
April 6, 2012 -- Updated 1117 GMT (1917 HKT)
snip
In another study, researchers from the University of Texas MD Anderson Cancer Center, in Houston, found that metformin was associated with better outcomes in diabetes patients with pancreatic cancer, an especially aggressive form of cancer.
The two-year survival rate was 30% among the 117 patients taking metformin and just 15% among 185 patients not on the drug.